Zoye

08/03 10:58

Injective Latest News: Hype Fades After ETF Buzz

Injective Latest News: Hype Fades After ETF Buzz

Injective saw a nice spike earlier after Cboe filed to list a Staked Injective ETF. However, it has since dropped to about $12.20. Analysts pointed to a breakout from an ascending triangle as the reason for the short-term gains. Fibonacci targets suggest levels at $18.95, $21.23, and $25.01 if momentum returns.analyticsinsight_2025-08-03_o7iyvq7y_Screenshot-2025-08-03-131300.webp

Crypto Rand noted that Injective now ranks among the top 10 blockchains by revenue, with the highest code commit count for Layer 1s. That’s solid fundamental progress. But without strong volume, INJ could keep slipping. 

Bitcoin Dominance: Holding Strong or Ready to Slide?

Bitcoin recently pulled back to $113,007 after touching $123,000 in mid-July. Even so, many analysts remain bullish. Some expect a year-end range between $130,000 and $150,000, depending on ETF flows and economic stability. Charles Schwab and Mike Novogratz both still believe in a $1 million Bitcoin by the end of 2025, but others say altcoins could take center stage for now.

Bitcoin is testing the neckline of its inverse head-and-shoulders pattern, sitting near the $109K–$112K support. A bounce here could lead to a breakout toward $150K. But if Bitcoin stalls again, it may open the door for lesser-known tokens to shine.analyticsinsight_2025-08-03_yrz9hlg3_Screenshot-2025-08-03-131320.webp

#Win 200 USDT: Is ETH Kicking Off Altcoin Season? #Do you think TREE is promising? #Whose “child” is ES — Solana or Ethereum?#HTX Crypto Gifts Carnival Is Live!#BTC price hits a new high of $120,000!

4分享